Endovascular Treatment of Medically Refractory Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage

Departments of Radiology, University of California, San Francisco, 94143-0628, USA.
American Journal of Neuroradiology (Impact Factor: 3.59). 11/2010; 31(10):1911-6. DOI: 10.3174/ajnr.A2183
Source: PubMed


CV following aneurysmal SAH is a significant cause of morbidity and mortality. We review our experiences using PTA and IA verapamil infusion for treating medically refractory cases.
We performed a retrospective review of patients with SAH admitted from July 2003 to January 2008.
Of 546 patients admitted within 72 hours of symptom onset, 231 patients (42%) developed symptomatic CV and 189 patients (35%) required endovascular therapy. A total of 346 endovascular sessions were performed consisting of 1 single angioplasty, 286 IA verapamil infusions, and 59 combined treatments. PTA was performed on 151 vessel segments, and IA verapamil was infused in 720 vessel segments. IA verapamil doses ranged from 2.0 to 30.0 mg per vessel segment and from 3.0 to 55.0 mg per treatment session. Repeat treatments were necessary in 102 patients (54%) for persistent, recurrent, or worsening CV. There were 6 treatment-related complications, of which 2 resulted in clinical worsening. No deaths were attributable to endovascular therapy. At follow-up, 115 patients (61%) had a good outcome and 55 patients (29%) had a poor outcome. Sixteen patients died from causes related to SAH, while 3 died from other medical complications.
Endovascular treatments are an integral part of managing patients with medically refractory CV. In our experience, PTA and IA verapamil are safe, with a low complication rate, but further studies are required to determine appropriate patient selection and treatment efficacy.

Download full-text


Available from: Van Halbach, Jan 25, 2016
    • "The current strategy for the treatment of clinical deterioration caused by DCI includes hypervolemia, hypertension, and hemodilution (triple H),[23] or hyperdynamic therapy.[81920] However, if symptoms are refractory to maximal medical management and vasospasm distributed diffusely to distal vasculatures, endovascular treatment such as intra-arterial vasodilator infusions provides a useful invasive therapeutic option.[9] "
    [Show abstract] [Hide abstract]
    ABSTRACT: Diffuse cerebral vasospasm following aneurysmal subarachnoid hemorrhage (SAH) refractory to medical management can be treated with intra-arterial administration of vasodilators, but valid bedside monitoring for the diagnosis and therapeutic assessment is poorly available. We demonstrate the successful application of regional cerebral oxygen saturation (rSO(2)) monitoring with multichannel near-infrared spectroscopy (NIRS) in assisting intra-arterial infusions of fasudil hydrochloride to a patient suffering from post-SAH vasospasm in the distal vascular territories. A 63-year-old man presented with SAH and intracerebral hematoma due to ruptured right middle cerebral artery aneurysm developed aphasia and right-sided weakness on day 9 after SAH onset. Delayed cerebral ischemia attributable to diffuse vasospasm in the distal territories of the left anterior and middle cerebral arteries was suspected. Since the symptoms persisted despite maximal hyperdynamic therapy with dobutamine, intra-arterial fasudil treatment in the setting of rSO(2) monitoring including the spasm-affected vascular territory with four-channel flexible NIRS sensors was subsequently performed. Decreased and fluctuating rSO(2) in angiographically documented vasospastic territories increased immediately after intra-arterial fasudil infusion in accordance with relief of vasospasm that correlated with neurological improvement. The procedure was repeated on day 11 since the effect was transient and neurological deterioration and reduction of rSO(2) recurred. The deficits resolved accompanied by uptake and maintenance of rSO (2) following the intra-arterial fasudil, resulting in favorable functional outcome. Continuous rSO(2) monitoring with multichannel NIRS is a feasible strategy to assist intraarterial fasudil therapy for detecting and treating the focal ischemic area exposed to diffuse vasospasm.
    No preview · Article · May 2011 · Surgical Neurology International
  • [Show abstract] [Hide abstract]
    ABSTRACT: In the vector controlled drive of AC motor, the dq-axis current control plays an important role of determining the overall system performance. Under some circumstances such as limited DC bus voltage, significantly sudden reference/load disturbance, the conventional PI controller would produce the saturated control voltage, causing the sluggish responses even though the integral antiwindup is employed. Also, the undesirable responses could be observed such as high overshoot, long settling time, etc. In this paper, a dq-axis current control technique for fast transient response in the vector controlled drive of permanent magnet synchronous motor is proposed. The Pontryagin's maximum principle is used to solve for the optimal-time voltage solution in the dq-axis current dynamical equations. Based on this principle, the technique can guarantee the dq-axis current transition from one point to another point with the minimum-time. Since the optimal-time voltages representing in synchronously rotating dq-axis, thus this optimal-time controller can easily replace two PI controllers for the dq-axis current loops in the existing vector controlled drive system without modification of system structure. Both simulation and experiment will be carried out to substantiate the proposed technique. The overall system will be implemented in a 32-bit fixed-point digital signal processor based controller (TMS320F2812 eZdsp board).
    No preview · Conference Paper · Sep 2004
  • Article: Vasospasm

    No preview · Article · Dec 2010 · Journal of Neurosurgery
Show more